Price Alert

Phio Pharmaceuticals Corp... (PHIO)

NASDAQ: PHIO · Real-Time Price · USD

2.21

0.02 (0.91%)

At close: Aug 15, 2025, 3:59 PM

2.12

-4.07%

After-hours: Aug 15, 2025, 07:34 PM EDT

Phio Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	13.28M	5.38M	5.39M	4.7M	6.47M	8.49M	8.41M	11.31M	9.04M	11.78M	14.48M	18.02M	20.46M	24.06M	26.53M	29.43M	32.7M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	3K	3K	3K	3K	6K	6K	24K	24K	27K	27K	27K	27K	18K	18K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	158K	354K	474K	594K	373K	832K	921K	728K	369K	665K	50K	50K	50K	50K	50K	50K	50K
Total Current Assets	13.44M	5.74M	5.86M	5.29M	6.85M	9.32M	9.33M	12.04M	9.4M	12.45M	15.38M	19.69M	21.67M	24.73M	27.45M	31.16M	33.32M
Property-Plant & Equipment	4K	2K	1K	1K	2K	39K	208K	255K	297K	344K	390K	429K	468K	416K	466K	484K	516K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	4K	2K	1K	4K	5K	42K	211K	261K	303K	368K	414K	456K	495K	443K	493K	502K	534K
Total Assets	13.44M	5.74M	5.87M	5.3M	6.85M	9.36M	9.54M	12.3M	9.71M	12.81M	15.79M	20.14M	22.16M	25.17M	27.94M	31.66M	33.86M
Account Payables	427K	253K	184K	335K	320K	657K	173K	641K	902K	779K	543K	1.15M	329K	283K	322K	348K	615K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	35K	70K	104K	138K	135K	132K	130K	127K	125K	112K	120K	118K
Other Current Liabilities	n/a	31K	n/a	n/a	n/a	685K	-70K	-104K	-138K	482K	-132K	-130K	-127K	1.96M	-112K	-120K	-118K
Total Current Liabilities	1.27M	1.01M	919K	1.52M	1.25M	1.63M	2.33M	2.39M	2.4M	1.8M	2.19M	3.04M	2.57M	3.07M	2.5M	2.58M	2.19M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.04M	172K	70K	104K	138K	170K	202K	234K	265K
Total Liabilities	1.27M	1.01M	919K	1.52M	1.25M	1.63M	2.33M	2.39M	2.4M	1.98M	2.26M	3.14M	2.71M	3.24M	2.7M	2.81M	2.46M
Total Debt	n/a	n/a	n/a	n/a	n/a	35K	70K	104K	138K	305K	202K	234K	265K	295K	314K	354K	383K
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1K	1K	1K	1K	1K	1K	1K
Retained Earnings	-148.13M	-146.36M	-144.73M	-143.21M	-141.36M	-139.21M	-137.31M	-134.53M	-131.98M	-128.38M	-125.65M	-122.07M	-119.54M	-116.9M	-113.45M	-109.71M	-107.02M
Comprehensive Income	n/a	n/a	n/a	n/a	0.00	-0.00	n/a	n/a	n/a	n/a	-0.00	n/a	0.00	0.00	0.00	n/a	-0.00
Shareholders Equity	12.17M	4.72M	4.95M	3.77M	5.6M	7.73M	7.21M	9.9M	7.31M	10.84M	13.53M	17M	19.45M	21.93M	25.25M	28.84M	31.4M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a